<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Leptospirosis: Treatment and prevention</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Leptospirosis: Treatment and prevention</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Leptospirosis: Treatment and prevention</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nick Day, DM, FRCP</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Stephen B Calderwood, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Morven S Edwards, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Keri K Hall, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Sep 05, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Leptospirosis is a zoonosis of the genus <em>Leptospira</em>. Synonyms include Weil's disease, Weil-Vasiliev disease, Swineherd's disease, rice-field fever, waterborne fever, nanukayami fever, cane-cutter fever, swamp fever, mud fever, Stuttgart disease, and Canicola fever.</p><p>The treatment and prevention of leptospirosis will be presented here. The epidemiology, microbiology, clinical manifestations, and diagnosis of this disease are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5527.html" rel="external">"Leptospirosis: Epidemiology, microbiology, clinical manifestations, and diagnosis"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">TREATMENT</span></p><p class="headingAnchor" id="H57685258"><span class="h2">Supportive care</span><span class="headingEndMark"> — </span>In the setting of severe illness due to leptospirosis, supportive care with renal replacement therapy, ventilatory support, and blood products may also be required [<a href="#rid1">1</a>]. In general, such management is the same as organ failure due to other causes of sepsis. </p><p>In one Brazilian study of patients with complications of leptospirosis including acute respiratory distress syndrome (ARDS) and acute kidney injury (AKI), daily hemodialysis was associated with lower mortality than alternate-day dialysis [<a href="#rid2">2</a>]. Hypokalemia is common in non-oliguric AKI associated with leptospirosis and should be corrected [<a href="#rid3">3</a>]. Recovery of renal function after the acute period is generally rapid and complete [<a href="#rid4">4-6</a>]. (See  <a class="medical medical_review" href="/z/d/html/1927.html" rel="external">"Kidney replacement therapy (dialysis) in acute kidney injury in adults: Indications, timing, and dialysis dose"</a>.)</p><p>For patients with ARDS, low net fluid intake to prevent pulmonary hemorrhage and lung-protective ventilation practices are appropriate. Extracorporeal membrane oxygenation has been used successfully in cases of leptospirosis with severe pulmonary hemorrhage, though there is no randomized evidence supporting routine use [<a href="#rid7">7</a>]. (See  <a class="medical medical_review" href="/z/d/html/1653.html" rel="external">"Acute respiratory distress syndrome: Ventilator management strategies for adults"</a>.)</p><p class="headingAnchor" id="H7863015"><span class="h2">Antimicrobial therapy</span></p><p class="headingAnchor" id="H7863193"><span class="h3">Clinical approach</span></p><p class="headingAnchor" id="H1077395431"><span class="h4">General principles</span><span class="headingEndMark"> — </span>Most cases of leptospirosis are self-limited in the absence of antimicrobial therapy; however, some patients do develop complications with significant morbidity and mortality. In general, if the illness is severe enough to come to clinical attention and the diagnosis is recognized, antibiotic therapy should be administered to shorten the duration of illness and reduce shedding of organisms in the urine. The approach varies with the clinical presentation.</p><p>A Jarisch-Herxheimer reaction may occur following antimicrobial therapy for leptospirosis; this is an acute inflammatory response to clearance of spirochetes from the circulation and is characterized clinically by fever, rigors, and hypotension [<a href="#rid8">8-10</a>]. In one series including 262 patients with leptospirosis, a Jarisch-Herxheimer reaction occurred in 21 percent of cases; risk factors included infection with the <em>L. interrogans</em> serogroup Australis strain and &lt;3 days between symptom onset and antibiotic therapy [<a href="#rid11">11</a>]. (See  <a class="medical medical_review" href="/z/d/html/7597.html" rel="external">"Syphilis: Treatment and monitoring", section on 'Jarisch-Herxheimer reaction'</a>.)</p><p class="headingAnchor" id="H127142090"><span class="h4">Mild disease</span><span class="headingEndMark"> — </span>For outpatients with mild disease, we favor treatment with <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a> (adults: 100 mg orally twice daily for 7 days; children: 2 mg/kg per day in two equally divided doses [not to exceed 200 mg daily] for 7 days) or <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">azithromycin</a> (adults: 500 mg orally once daily for three days; children: 10 mg/kg orally on day 1 [maximum dose 500 mg/day] followed by 5 mg/kg/day orally once daily on subsequent days [maximum dose 250 mg/day]). These agents also have activity against rickettsial disease, which can be confused with leptospirosis.</p><p>For pregnant women, we favor treatment with either <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">azithromycin</a> (500 mg orally once daily for three days) or <a class="drug drug_general" data-topicid="8673" href="/z/d/drug information/8673.html" rel="external">amoxicillin</a> (25 to 50 mg/kg in three equally divided doses [maximum 500 mg/dose] for seven days). Azithromycin is preferred over amoxicillin if the differential diagnosis includes rickettsial infection. </p><p class="headingAnchor" id="H4059644898"><span class="h4">Severe disease</span><span class="headingEndMark"> — </span>For hospitalized adults with severe disease, we favor treatment with penicillin (1.5 million units intravenously [IV] every six hours), <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a> (100 mg IV twice daily), <a class="drug drug_general" data-topicid="9229" href="/z/d/drug information/9229.html" rel="external">ceftriaxone</a> (1 to 2 g IV once daily), or <a class="drug drug_general" data-topicid="9221" href="/z/d/drug information/9221.html" rel="external">cefotaxime</a> (1 g IV every six hours). The duration of treatment in severe disease is usually seven days.</p><p>For hospitalized children with severe disease, we favor treatment with penicillin (250,000 to 400,000 units/kg IV per day in four to six divided doses [maximum dose 6 to 12 million units daily]), <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a> (4 mg/kg IV per day in two equally divided doses [maximum dose 200 mg/day]), <a class="drug drug_general" data-topicid="9229" href="/z/d/drug information/9229.html" rel="external">ceftriaxone</a> (80 to 100 mg/kg IV once daily [maximum dose 2 g daily]), or <a class="drug drug_general" data-topicid="9221" href="/z/d/drug information/9221.html" rel="external">cefotaxime</a> (100 to 150 mg/kg IV per day in three to four equally divided doses). For children who cannot tolerate the above agents, <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">azithromycin</a> is an acceptable alternative agent (10 mg/kg IV on day 1 [maximum dose 500 mg/day], followed by 5 mg/kg/day IV once daily on subsequent days [maximum dose 250 mg/day]). The duration of treatment in severe disease is usually seven days.</p><p><a class="drug drug_general" data-topicid="9986" href="/z/d/drug information/9986.html" rel="external">Tetracycline</a> antibiotics may cause permanent tooth discoloration for children &lt;8 years if used repeatedly. However, <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a> binds less readily to calcium than other tetracyclines and may be used for ≤21 days in children of all ages [<a href="#rid12">12</a>].</p><p>Pregnant women with severe leptospirosis may be treated with penicillin, <a class="drug drug_general" data-topicid="9229" href="/z/d/drug information/9229.html" rel="external">ceftriaxone</a>, <a class="drug drug_general" data-topicid="9221" href="/z/d/drug information/9221.html" rel="external">cefotaxime</a>, or <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">azithromycin</a>. <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">Doxycycline</a> appears to be safer in pregnancy than other tetracyclines; it should be considered if the diagnosis of leptospirosis is not certain and murine typhus is a possible alternative diagnosis (since murine typhus does not respond as well to azithromycin as to doxycycline) [<a href="#rid13">13</a>].</p><p>Penicillin and cephalosporins lack activity against rickettsiaceae and so should be avoided in circumstances in which leptospirosis cannot be definitively distinguished from rickettsial infection [<a href="#rid14">14</a>]. Intravenous <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a> is an appropriate therapy for treatment of severely ill patients in areas endemic for both leptospirosis and rickettsial infection.</p><p class="headingAnchor" id="H3"><span class="h3">Efficacy</span><span class="headingEndMark"> — </span>Whether antimicrobials produce a beneficial effect in leptospirosis remains unclear, mainly due to the paucity of clinical trial evidence in the disease. A recent meta-analysis of 10 clinical trials (the most recent from 2007) found that antimicrobial therapy did not affect mortality, the incidence of oliguria/anuria, the need for dialysis treatment, time to creatinine normalization, incidence of jaundice, or liver function normalization time [<a href="#rid15">15</a>]. In a retrospective case-control study from New Caledonia, risk factors for the development of severe leptospirosis included a delay of &gt;2 days following the start of symptoms in the initiation of antibiotic treatment, suggesting that antibiotics may reduce the likelihood of progression to severe disease in some cases [<a href="#rid16">16</a>].</p><p>Activity against leptospires has been observed in vitro and in animal models for penicillins, cephalosporins, tetracyclines, <a class="drug drug_general" data-topicid="9241" href="/z/d/drug information/9241.html" rel="external">chloramphenicol</a>, fluoroquinolones, macrolides, and telithromycin, and in vitro studies have demonstrated that carbapenems and <a class="drug drug_general" data-topicid="9047" href="/z/d/drug information/9047.html" rel="external">aztreonam</a> also have excellent activity against leptospires [<a href="#rid17">17-21</a>]. Antibiotic susceptibility testing is not done routinely as it is difficult to do and, thus far, resistance does not appear to be a problem, based on susceptibility studies that have been done as well as favorable clinical response to the antibiotics generally used for treatment. The development of a new solid media (LVW agar) for leptospirosis may facilitate more routine testing, which will enable quicker identification of drug resistance should it arise in the setting of inadequate clinical response [<a href="#rid22">22</a>].</p><p>Studies from Thailand have noted comparable efficacy for penicillin, <a class="drug drug_general" data-topicid="9229" href="/z/d/drug information/9229.html" rel="external">ceftriaxone</a>, <a class="drug drug_general" data-topicid="9221" href="/z/d/drug information/9221.html" rel="external">cefotaxime</a>, and <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a> for treatment of leptospirosis. In one study of 173 patients with severe leptospirosis, <a class="drug drug_general" data-topicid="9749" href="/z/d/drug information/9749.html" rel="external">penicillin G</a> (1.5 million units IV every six hours for seven days) was compared with ceftriaxone (1 g IV every 24 hours for seven days) [<a href="#rid23">23</a>]. In another study, 540 patients with suspected severe leptospirosis (264 serologically confirmed) were randomized to treatment with cefotaxime (1 g IV every six hours for seven days), penicillin G (1.5 million units IV every six hours for seven days), or doxycycline (200 mg initially followed by 100 mg IV every 12 hours for seven days) [<a href="#rid14">14</a>]. In both studies, all regimens had similar efficacy for leptospirosis but did not include a placebo arm [<a href="#rid24">24</a>].</p><p>In another study, 296 patients in Thailand with suspected leptospirosis or scrub typhus were randomized to receive <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a> (200 mg initially followed by 100 mg orally every 12 hours for seven days) or <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">azithromycin</a> (2 g on day 1 followed by 1 g daily for two more days) [<a href="#rid25">25</a>]. There was no difference in fever clearance times; oral azithromycin was better tolerated than doxycycline.</p><p class="headingAnchor" id="H7863340"><span class="h2">Role of corticosteroids and plasmapheresis</span><span class="headingEndMark"> — </span>Use of intravenous corticosteroid therapy has been proposed given the vasculitic nature of severe leptospirosis, particularly in the setting of pulmonary involvement; thus far, there is insufficient evidence for routine use of corticosteroids. Some reports have suggested a possible benefit to use of steroids as an adjunct to antibiotic therapy in severe disease [<a href="#rid26">26-30</a>]; further study is needed. </p><p>Plasmapheresis has also been used in severe leptospirosis and there is some nonrandomized evidence suggesting benefit [<a href="#rid31">31,32</a>], but there is no high-quality randomized evidence to justify routine use [<a href="#rid7">7</a>].</p><p class="headingAnchor" id="H8"><span class="h1">PREVENTION</span><span class="headingEndMark"> — </span>Several human vaccines have been developed; all are serovar specific, developed for specific epidemiologic circumstances. None is widely available. Prevention measures include avoiding potential sources of infection, administration of prophylaxis for individuals at high risk of exposure, and animal vaccination.</p><p>The most important control measures for preventing human leptospirosis include avoiding potential sources of infection such as stagnant water and animal farm water runoff, rodent control, and protection of food from animal contamination.</p><p>Antimicrobial prophylaxis for individuals at high risk of exposure may be useful in some settings, although the evidence for this is weak as clinical studies have been heterogenous in design and mostly underpowered [<a href="#rid15">15</a>]. Among more than 700 individuals in the Andaman Islands (a highly endemic setting in Southeast Asia where outbreaks of leptospirosis related to flooding are common) randomized to prophylaxis with <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a> 200 mg orally weekly or placebo, clinical infection rates were lower among those who received doxycycline (3.1 versus 6.8 percent), although there was no difference in seroconversion rates [<a href="#rid33">33</a>]. In another study including more than 900 soldiers deployed for jungle training in Panama, fewer cases of leptospirosis were observed among those who received doxycycline prophylaxis (200 mg orally every week for two to three weeks and at the end of exposure) compared with placebo (1 versus 20 cases) [<a href="#rid34">34</a>].</p><p>Vaccination of domestic and farm animals against leptospirosis can provide variable levels of protection [<a href="#rid35">35-38</a>]. Some immunized animals become infected and excrete leptospires in their urine.</p><p class="headingAnchor" id="H2857935"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/z/d/html/83289.html" rel="external">"Patient education: Leptospirosis (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H9"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical approach</strong> – The majority of leptospirosis infections are self-limiting. Antimicrobial therapy shortens the duration of illness and reduces shedding of the organism in the urine. (See <a class="local">'Clinical approach'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mild leptospirosis</strong> – We suggest administration of antimicrobial therapy for treatment of patients with mild leptospirosis (<a class="grade" href="https:///uptodate/show/grade_5" rel="external">Grade 2B</a>). We favor treatment with oral <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a> or oral <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">azithromycin</a>; these agents are also effective for rickettsial infections, which can be difficult to distinguish from leptospirosis. Doxycycline should be avoided in pregnant women; reasonable alternatives include azithromycin or <a class="drug drug_general" data-topicid="8673" href="/z/d/drug information/8673.html" rel="external">amoxicillin</a>. (See <a class="local">'Clinical approach'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Severe leptospirosis</strong> – We recommend administration of antimicrobial therapy for treatment of patients with severe leptospirosis (<a class="grade" href="https:///uptodate/show/grade_2" rel="external">Grade 1B</a>). Parenteral penicillin, <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a>, and third-generation cephalosporins are all acceptable options. Penicillin and cephalosporins lack activity against rickettsiaceae and so should not be used for circumstances in which leptospirosis cannot be definitively distinguished from rickettsial infection. (See <a class="local">'Antimicrobial therapy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevention</strong> – There is no human vaccine widely available. Prevention measures include avoiding potential sources of infection, administration of prophylaxis for individuals at high risk of exposure, and animal vaccination. Prophylaxis with <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a> is reasonable for individuals with high likelihood for exposure to leptospires in endemic environments over a defined period. (See <a class="local">'Prevention'</a> above.)</p><p></p><p class="headingAnchor" id="H18474598"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Dr. E Dale Everett, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Wiwanitkit V. Comparison between blood exchange and classical therapy for acute renal failure in Weil's disease: appraisal on Thai reports. Nephrology (Carlton) 2006; 11:481.</a></li><li><a class="nounderline abstract_t">Andrade L, Cleto S, Seguro AC. Door-to-dialysis time and daily hemodialysis in patients with leptospirosis: impact on mortality. Clin J Am Soc Nephrol 2007; 2:739.</a></li><li><a class="nounderline abstract_t">Abdulkader RC, Seguro AC, Malheiro PS, et al. Peculiar electrolytic and hormonal abnormalities in acute renal failure due to leptospirosis. Am J Trop Med Hyg 1996; 54:1.</a></li><li><a class="nounderline abstract_t">Daher Ede F, Zanetta DM, Abdulkader RC. Pattern of renal function recovery after leptospirosis acute renal failure. Nephron Clin Pract 2004; 98:c8.</a></li><li><a class="nounderline abstract_t">Herath NJ, Kularatne SA, Weerakoon KG, et al. Long term outcome of acute kidney injury due to leptospirosis? A longitudinal study in Sri Lanka. BMC Res Notes 2014; 7:398.</a></li><li><a class="nounderline abstract_t">Andrade L, de Francesco Daher E, Seguro AC. Leptospiral nephropathy. Semin Nephrol 2008; 28:383.</a></li><li><a class="nounderline abstract_t">Fonseka CL, Lekamwasam S. Role of Plasmapheresis and Extracorporeal Membrane Oxygenation in the Treatment of Leptospirosis Complicated with Pulmonary Hemorrhages. J Trop Med 2018; 2018:4520185.</a></li><li><a class="nounderline abstract_t">Guerrier G, D'Ortenzio E. The Jarisch-Herxheimer reaction in leptospirosis: a systematic review. PLoS One 2013; 8:e59266.</a></li><li><a class="nounderline abstract_t">Tunbridge AJ, Dockrell DH, Channer KS, McKendrick MW. A breathless triathlete. Lancet 2002; 359:130.</a></li><li><a class="nounderline abstract_t">Takamizawa S, Gomi H, Shimizu Y, et al. Leptospirosis and Jarisch-Herxheimer reaction. QJM 2015; 108:967.</a></li><li><a class="nounderline abstract_t">Guerrier G, Lefèvre P, Chouvin C, D'Ortenzio E. Jarisch-Herxheimer Reaction Among Patients with Leptospirosis: Incidence and Risk Factors. Am J Trop Med Hyg 2017.</a></li><li class="breakAll">American Academy of Pediatrics. Red Book: 2021-2024 Report of the Committee on Infectious Diseases, 32 ed, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (Eds), American Academy of Pediatrics, Itasca, IL 2021.</li><li><a class="nounderline abstract_t">Cross R, Ling C, Day NP, et al. Revisiting doxycycline in pregnancy and early childhood--time to rebuild its reputation? Expert Opin Drug Saf 2016; 15:367.</a></li><li><a class="nounderline abstract_t">Suputtamongkol Y, Niwattayakul K, Suttinont C, et al. An open, randomized, controlled trial of penicillin, doxycycline, and cefotaxime for patients with severe leptospirosis. Clin Infect Dis 2004; 39:1417.</a></li><li><a class="nounderline abstract_t">Guzmán Pérez M, Blanch Sancho JJ, Segura Luque JC, et al. Current Evidence on the Antimicrobial Treatment and Chemoprophylaxis of Human Leptospirosis: A Meta-Analysis. Pathogens 2021; 10.</a></li><li><a class="nounderline abstract_t">Tubiana S, Mikulski M, Becam J, et al. Risk factors and predictors of severe leptospirosis in New Caledonia. PLoS Negl Trop Dis 2013; 7:e1991.</a></li><li><a class="nounderline abstract_t">Murray CK, Hospenthal DR. Determination of susceptibilities of 26 Leptospira sp. serovars to 24 antimicrobial agents by a broth microdilution technique. Antimicrob Agents Chemother 2004; 48:4002.</a></li><li><a class="nounderline abstract_t">Moon JE, Ellis MW, Griffith ME, et al. Efficacy of macrolides and telithromycin against leptospirosis in a hamster model. Antimicrob Agents Chemother 2006; 50:1989.</a></li><li><a class="nounderline abstract_t">Alt DP, Zuerner RL, Bolin CA. Evaluation of antibiotics for treatment of cattle infected with Leptospira borgpetersenii serovar hardjo. J Am Vet Med Assoc 2001; 219:636.</a></li><li><a class="nounderline abstract_t">Griffith ME, Moon JE, Johnson EN, et al. Efficacy of fluoroquinolones against Leptospira interrogans in a hamster model. Antimicrob Agents Chemother 2007; 51:2615.</a></li><li><a class="nounderline abstract_t">Ressner RA, Griffith ME, Beckius ML, et al. Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira. Antimicrob Agents Chemother 2008; 52:2750.</a></li><li><a class="nounderline abstract_t">Wuthiekanun V, Amornchai P, Paris DH, et al. Rapid isolation and susceptibility testing of Leptospira spp. using a new solid medium, LVW agar. Antimicrob Agents Chemother 2013; 57:297.</a></li><li><a class="nounderline abstract_t">Panaphut T, Domrongkitchaiporn S, Vibhagool A, et al. Ceftriaxone compared with sodium penicillin g for treatment of severe leptospirosis. Clin Infect Dis 2003; 36:1507.</a></li><li><a class="nounderline abstract_t">Brett-Major DM, Coldren R. Antibiotics for leptospirosis. Cochrane Database Syst Rev 2012; :CD008264.</a></li><li><a class="nounderline abstract_t">Phimda K, Hoontrakul S, Suttinont C, et al. Doxycycline versus azithromycin for treatment of leptospirosis and scrub typhus. Antimicrob Agents Chemother 2007; 51:3259.</a></li><li><a class="nounderline abstract_t">Kularatne SA, Budagoda BD, de Alwis VK, et al. High efficacy of bolus methylprednisolone in severe leptospirosis: a descriptive study in Sri Lanka. Postgrad Med J 2011; 87:13.</a></li><li><a class="nounderline abstract_t">Thunga G, John J, Sam KG, et al. Role of high-dose corticosteroid for the treatment of leptospirosis-induced pulmonary hemorrhage. J Clin Pharmacol 2012; 52:114.</a></li><li><a class="nounderline abstract_t">Minor K, Mohan A. Severe leptospirosis: treatment with intravenous corticosteroids and supportive care. Am J Emerg Med 2013; 31:449.e1.</a></li><li><a class="nounderline abstract_t">Azevedo AF, Miranda-Filho Dde B, Henriques-Filho GT, et al. Randomized controlled trial of pulse methyl prednisolone × placebo in treatment of pulmonary involvement associated with severe leptospirosis. [ISRCTN74625030]. BMC Infect Dis 2011; 11:186.</a></li><li><a class="nounderline abstract_t">Rodrigo C, Lakshitha de Silva N, Goonaratne R, et al. High dose corticosteroids in severe leptospirosis: a systematic review. Trans R Soc Trop Med Hyg 2014; 108:743.</a></li><li><a class="nounderline abstract_t">Trivedi SV, Vasava AH, Bhatia LC, et al. Plasma exchange with immunosuppression in pulmonary alveolar haemorrhage due to leptospirosis. Indian J Med Res 2010; 131:429.</a></li><li><a class="nounderline abstract_t">Herath N, Uluwattage W, Weliwitiya T, et al. Sequel and therapeutic modalities of leptospirosis associated severe pulmonary haemorrhagic syndrome (SPHS); a Sri Lankan experience. BMC Infect Dis 2019; 19:451.</a></li><li><a class="nounderline abstract_t">Sehgal SC, Sugunan AP, Murhekar MV, et al. Randomized controlled trial of doxycycline prophylaxis against leptospirosis in an endemic area. Int J Antimicrob Agents 2000; 13:249.</a></li><li><a class="nounderline abstract_t">Takafuji ET, Kirkpatrick JW, Miller RN, et al. An efficacy trial of doxycycline chemoprophylaxis against leptospirosis. N Engl J Med 1984; 310:497.</a></li><li><a class="nounderline abstract_t">André-Fontaine G, Branger C, Gray AW, Klaasen HL. Comparison of the efficacy of three commercial bacterins in preventing canine leptospirosis. Vet Rec 2003; 153:165.</a></li><li><a class="nounderline abstract_t">Hancock GA, Wilks CR, Kotiw M, Allen JD. The long term efficacy of a hardjo-pomona vaccine in preventing leptospiruria in cattle exposed to natural challenge with Leptospira interrogans serovar hardjo. Aust Vet J 1984; 61:54.</a></li><li><a class="nounderline abstract_t">Rinehart CL, Zimmerman AD, Buterbaugh RE, et al. Efficacy of vaccination of cattle with the Leptospira interrogans serovar hardjo type hardjoprajitno component of a pentavalent Leptospira bacterin against experimental challenge with Leptospira borgpetersenii serovar hardjo type hardjo-bovis. Am J Vet Res 2012; 73:735.</a></li><li><a class="nounderline abstract_t">Sykes JE, Hartmann K, Lunn KF, et al. 2010 ACVIM small animal consensus statement on leptospirosis: diagnosis, epidemiology, treatment, and prevention. J Vet Intern Med 2011; 25:1.</a></li></ol></div><div id="topicVersionRevision">Topic 5524 Version 24.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17014569" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Comparison between blood exchange and classical therapy for acute renal failure in Weil's disease: appraisal on Thai reports.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17699490" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Door-to-dialysis time and daily hemodialysis in patients with leptospirosis: impact on mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8651360" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Peculiar electrolytic and hormonal abnormalities in acute renal failure due to leptospirosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15361699" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Pattern of renal function recovery after leptospirosis acute renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24964804" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Long term outcome of acute kidney injury due to leptospirosis? A longitudinal study in Sri Lanka.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18620961" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Leptospiral nephropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30631369" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Role of Plasmapheresis and Extracorporeal Membrane Oxygenation in the Treatment of Leptospirosis Complicated with Pulmonary Hemorrhages.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23555644" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : The Jarisch-Herxheimer reaction in leptospirosis: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11809256" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : A breathless triathlete.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25862773" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Leptospirosis and Jarisch-Herxheimer reaction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28115662" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Jarisch-Herxheimer Reaction Among Patients with Leptospirosis: Incidence and Risk Factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28115662" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Jarisch-Herxheimer Reaction Among Patients with Leptospirosis: Incidence and Risk Factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26680308" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Revisiting doxycycline in pregnancy and early childhood--time to rebuild its reputation?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15546074" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : An open, randomized, controlled trial of penicillin, doxycycline, and cefotaxime for patients with severe leptospirosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34578157" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Current Evidence on the Antimicrobial Treatment and Chemoprophylaxis of Human Leptospirosis: A Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23326614" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Risk factors and predictors of severe leptospirosis in New Caledonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15388465" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Determination of susceptibilities of 26 Leptospira sp. serovars to 24 antimicrobial agents by a broth microdilution technique.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16723556" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Efficacy of macrolides and telithromycin against leptospirosis in a hamster model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11549093" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Evaluation of antibiotics for treatment of cattle infected with Leptospira borgpetersenii serovar hardjo.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17470646" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Efficacy of fluoroquinolones against Leptospira interrogans in a hamster model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18411316" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23114772" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Rapid isolation and susceptibility testing of Leptospira spp. using a new solid medium, LVW agar.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12802748" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Ceftriaxone compared with sodium penicillin g for treatment of severe leptospirosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22336839" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Antibiotics for leptospirosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17638700" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Doxycycline versus azithromycin for treatment of leptospirosis and scrub typhus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21106802" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : High efficacy of bolus methylprednisolone in severe leptospirosis: a descriptive study in Sri Lanka.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21343344" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Role of high-dose corticosteroid for the treatment of leptospirosis-induced pulmonary hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22980361" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Severe leptospirosis: treatment with intravenous corticosteroids and supportive care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21718474" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Randomized controlled trial of pulse methyl prednisolone×placebo in treatment of pulmonary involvement associated with severe leptospirosis. [ISRCTN74625030].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25266477" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : High dose corticosteroids in severe leptospirosis: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20418558" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Plasma exchange with immunosuppression in pulmonary alveolar haemorrhage due to leptospirosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31113404" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Sequel and therapeutic modalities of leptospirosis associated severe pulmonary haemorrhagic syndrome (SPHS); a Sri Lankan experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10755239" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Randomized controlled trial of doxycycline prophylaxis against leptospirosis in an endemic area.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6363930" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : An efficacy trial of doxycycline chemoprophylaxis against leptospirosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12934727" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Comparison of the efficacy of three commercial bacterins in preventing canine leptospirosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6732669" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : The long term efficacy of a hardjo-pomona vaccine in preventing leptospiruria in cattle exposed to natural challenge with Leptospira interrogans serovar hardjo.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22533408" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Efficacy of vaccination of cattle with the Leptospira interrogans serovar hardjo type hardjoprajitno component of a pentavalent Leptospira bacterin against experimental challenge with Leptospira borgpetersenii serovar hardjo type hardjo-bovis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21155890" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : 2010 ACVIM small animal consensus statement on leptospirosis: diagnosis, epidemiology, treatment, and prevention.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
